Pathogenic and Regulatory Roles of Fibrinolytic Factors in Autoimmune Diseases
Author:
Open Access
- 23 September 2025
- journal article
- review article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 47 (10) , 790
Abstract
Autoimmune diseases arise from complex interactions of genetic, environmental, and hormonal factors, yet their precise causes remain elusive. Beyond its canonical role in fibrin degradation, the fibrinolytic system is increasingly recognized as both a pathogenic driver and a regulatory modulator in autoimmunity. Key factors—plasminogen (Plg), plasmin, α2-antiplasmin (α2AP), tissue-type plasminogen activator (tPA), urokinase-type plasminogen activator (uPA), its receptor (uPAR), and plasminogen activator inhibitor-1 (PAI-1)—not only reflect secondary responses to vascular and immune dysregulation but also actively shape innate and adaptive immunity. They influence macrophage activation, dendritic cell maturation, T cell responses, and cytokine production, thereby bridging coagulation, inflammation, and tissue repair. This review integrates current evidence on the dual pathogenic and regulatory roles of fibrinolytic factors, organizing autoimmune diseases into systemic, organ-specific, and secondary syndromes. We further discuss how the imbalance of fibrinolysis can either promote inflammatory persistence or, conversely, facilitate resolution through fibrin clearance and immune homeostasis. By highlighting this bidirectional influence, the review aims to refine our understanding of fibrinolytic components as both contributors to and regulators of autoimmune disease pathogenesis.Keywords
This publication has 183 references indexed in Scilit:
- Plasminogen Activator Inhibitor‐1 in the Pathophysiology of Late Life DepressionInternational Journal of Geriatric Psychiatry, 2024
- Systemic Lupus ErythematosusJAMA, 2024
- Ulcerative Colitis in AdultsJAMA, 2023
- Rheumatoid Arthritis Morning Stiffness Is Associated With Synovial Fibrin and NeutrophilsArthritis & Rheumatology, 2019
- The blocking of uPAR suppresses lipopolysaccharide-induced inflammatory osteoclastogenesis and the resultant bone loss through attenuation of integrin β3/Akt pathwayImmunity, Inflammation and Disease, 2016
- Alpha2‐antiplasmin regulates the development of dermal fibrosis in mice by prostaglandin F2αsynthesis through adipose triglyceride lipase/calcium‐independent phospholipase A2Arthritis & Rheumatism, 2012
- β2‐glycoprotein i is a cofactor for tissue plasminogen activator–mediated plasminogen activationArthritis & Rheumatism, 2009
- Contrasting roles of plasminogen deficiency in different rheumatoid arthritis modelsArthritis & Rheumatism, 2005
- Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patientsArthritis & Rheumatism, 2002
- Analysis of intraarticular fibrinolytic pathways in patients with inflammatory and noninflammatory joint diseasesArthritis & Rheumatism, 1992